NCT03340506 2026-04-01
Dabrafenib and/or Trametinib Rollover Study
Novartis
Phase 4 Recruiting
Novartis
Institut Paoli-Calmettes
Merck Sharp & Dohme LLC
Assistance Publique Hopitaux De Marseille
Peter MacCallum Cancer Centre, Australia
Dartmouth-Hitchcock Medical Center